CIK 0001642380
- Non-accelerated filer
- Smaller reporting company
Insight Molecular Diagnostics Inc.
Sign in to watch- Ticker
- IMDX
- Exchange
- Nasdaq
- Industry
- In Vitro & In Vivo Diagnostic Substances
- FY end
- Dec 31
- Incorporated
- CA
- Entity type
- Operating
- EIN
- 271041563
- Phone
- +1 949-409-7600
- Business address
- 2 INTERNATIONAL PLAZA DR., SUITE 510, NASHVILLE, TN, 37217
- Former names
- OncoCyte Corp, Oncocyte Corp
- Open-market buys, last 90 days
- $5,999,999
- in 1 filing
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$5,999,999. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-11-17 | SMITH PATRICK W 10% owner | Other acquisition | +1,142,857 | $1.75 | $2.0M | 4,401,342 |
| 2025-02-07 | SMITH PATRICK W 10% owner | Purchase | +1,077,600 | $2.05 | $2.2M | 2,872,671 |
| 2025-02-07 | SMITH PATRICK W 10% owner | Other acquisition | +385,814 | $2.05 | $791K | 3,258,485 |
| 2025-02-04 | SMITH PATRICK W 10% owner | Purchase | +25 | $2.02 | $51 | 1,795,071 |
| 2025-01-31 | SMITH PATRICK W 10% owner | Purchase | +890 | $2.01 | $2K | 1,795,046 |
| 2025-01-30 | SMITH PATRICK W 10% owner | Purchase | +318 | $2.01 | $639 | 1,794,156 |
| 2025-01-29 | SMITH PATRICK W 10% owner | Purchase | +3,880 | $2.01 | $8K | 1,793,838 |
| 2025-01-14 | SMITH PATRICK W 10% owner | Purchase | +100 | $2.08 | $208 | 1,779,672 |
| 2025-01-14 | SMITH PATRICK W 10% owner | Purchase | +10,286 | $2.15 | $22K | 1,789,958 |
| 2025-01-13 | SMITH PATRICK W 10% owner | Purchase | +5,669 | $2.08 | $12K | 1,779,572 |
| 2024-12-26 | SMITH PATRICK W 10% owner | Purchase | +90,219 | $2.13 | $192K | 1,773,903 |
Page 1 of 1 · 11 trades